SOTERA HEALTH COMPANY Increase (Decrease) in Accounts Payable
SOTERA HEALTH COMPANY (SHC) reported Increase (Decrease) in Accounts Payable of $13.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $10.60M.
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.81M, a 75.88% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $7.99M.
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$8.38M, a 394.58% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for fiscal 2025 was $5.18M.
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for fiscal 2024 was -$6.64M.
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for fiscal 2023 was -$5.33M, a 581.75% decline from fiscal 2022.
- SOTERA HEALTH COMPANY increase (decrease) in accounts payable for fiscal 2022 was $1.11M, a 94.40% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.41M 10-Q · filed 2026-08-06 | $21.40M derived: sum of 3 quarters · filed 2026-08-06 | $13.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.81M 10-Q · filed 2026-05-05 | $10.80M derived: sum of 2 quarters · filed 2026-05-05 | $2.43M derived: sum of 3 quarters · filed 2026-05-05 | -$3.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$388.00K derived: sum of 2 quarters · filed 2026-02-24 | -$6.49M derived: sum of 3 quarters · filed 2026-08-06 | $5.18M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$8.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$14.47M derived: sum of 2 quarters · filed 2026-08-06 | -$2.80M 10-Q · filed 2025-11-04 | -$10.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.57M 10-Q · filed 2026-08-06 | -$1.96M derived: sum of 3 quarters · filed 2026-08-06 | $888.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $11.67M 10-Q · filed 2026-05-05 | $4.14M derived: sum of 2 quarters · filed 2026-05-05 | $6.99M derived: sum of 3 quarters · filed 2026-05-05 | $12.31M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$7.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$4.68M derived: sum of 2 quarters · filed 2026-02-24 | $636.00K derived: sum of 3 quarters · filed 2026-02-24 | -$6.64M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $8.16M derived: sum of 2 quarters · filed 2025-11-04 | $884.00K 10-Q · filed 2025-11-04 | $12.96M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $5.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.96M 10-Q · filed 2025-08-08 | $10.12M derived: sum of 3 quarters · filed 2026-02-24 | $13.03M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$7.28M 10-Q · filed 2025-05-01 | $4.80M derived: sum of 2 quarters · filed 2026-02-24 | $7.71M derived: sum of 3 quarters · filed 2026-02-24 | -$3.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $14.99M derived: sum of 2 quarters · filed 2026-02-24 | $4.28M derived: sum of 3 quarters · filed 2026-02-24 | -$5.33M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$7.80M derived: sum of 2 quarters · filed 2024-11-05 | -$17.41M 10-Q · filed 2024-11-05 | -$2.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$10.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$20.32M 10-Q · filed 2024-08-05 | -$5.85M derived: sum of 3 quarters · filed 2025-02-27 | -$9.22M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$9.61M 10-Q · filed 2024-05-02 | $4.86M derived: sum of 2 quarters · filed 2025-02-27 | $1.49M derived: sum of 3 quarters · filed 2025-02-27 | $4.24M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $14.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.10M derived: sum of 2 quarters · filed 2025-02-27 | $13.85M derived: sum of 3 quarters · filed 2025-02-27 | $1.11M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$625.00K derived: sum of 2 quarters · filed 2023-11-01 | -$13.37M 10-Q · filed 2023-11-01 | $6.68M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$9.99M 10-Q · filed 2023-08-03 | $10.06M derived: sum of 3 quarters · filed 2024-02-27 | -$5.31M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$12.74M 10-Q · filed 2023-05-03 | $7.31M derived: sum of 2 quarters · filed 2024-02-27 | -$8.06M derived: sum of 3 quarters · filed 2024-02-27 | $394.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $20.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.68M derived: sum of 2 quarters · filed 2024-02-27 | $13.14M derived: sum of 3 quarters · filed 2024-02-27 | $19.76M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$15.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$6.92M derived: sum of 2 quarters · filed 2022-11-02 | -$291.00K 10-Q · filed 2022-11-02 | $1.53M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $8.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $15.08M 10-Q · filed 2022-08-04 | $16.91M derived: sum of 3 quarters · filed 2023-02-28 | $18.01M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $6.63M 10-Q · filed 2022-05-05 | $8.45M derived: sum of 2 quarters · filed 2023-02-28 | $9.55M derived: sum of 3 quarters · filed 2023-02-28 | $1.34M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.93M derived: sum of 2 quarters · filed 2023-02-28 | -$5.29M derived: sum of 3 quarters · filed 2023-02-28 | -$6.02M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$7.12M derived: sum of 2 quarters · filed 2021-11-10 | -$7.85M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$8.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$8.95M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$733.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$8.97M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |